We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, BIOA discontinued its lead obesity study
What is covered in the Full Insight:
Review of Biopharma News
BioAge Labs Obesity Study Discontinuation
Janux Therapeutics Prostate Cancer Data
PTC Therapeutics and Novartis Deal
Senti Biosciences AML Trial Results
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.